

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of light stimulus involved in sensory perception (GO:0050962) | 9.94934419 |
| 2 | detection of light stimulus involved in visual perception (GO:0050908) | 9.94934419 |
| 3 | retinal rod cell development (GO:0046548) | 9.94016121 |
| 4 | photoreceptor cell development (GO:0042461) | 9.51046241 |
| 5 | photoreceptor cell maintenance (GO:0045494) | 9.13241387 |
| 6 | eye photoreceptor cell development (GO:0042462) | 9.06108668 |
| 7 | protein-chromophore linkage (GO:0018298) | 8.55809447 |
| 8 | phototransduction, visible light (GO:0007603) | 8.18012282 |
| 9 | phototransduction (GO:0007602) | 8.12072653 |
| 10 | detection of visible light (GO:0009584) | 7.98400262 |
| 11 | detection of light stimulus (GO:0009583) | 7.88719850 |
| 12 | visual perception (GO:0007601) | 6.92908586 |
| 13 | sensory perception of light stimulus (GO:0050953) | 6.85898654 |
| 14 | GMP metabolic process (GO:0046037) | 6.74800872 |
| 15 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.81376482 |
| 16 | detection of external stimulus (GO:0009581) | 5.53845987 |
| 17 | cellular response to light stimulus (GO:0071482) | 5.53158441 |
| 18 | detection of abiotic stimulus (GO:0009582) | 5.43407738 |
| 19 | regulation of guanylate cyclase activity (GO:0031282) | 5.20078072 |
| 20 | eye photoreceptor cell differentiation (GO:0001754) | 5.15559921 |
| 21 | photoreceptor cell differentiation (GO:0046530) | 5.15559921 |
| 22 | retina development in camera-type eye (GO:0060041) | 4.81429197 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.59897588 |
| 24 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.38534223 |
| 25 | regulation of cGMP metabolic process (GO:0030823) | 4.33588046 |
| 26 | regulation of bile acid biosynthetic process (GO:0070857) | 4.12586205 |
| 27 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.07839797 |
| 28 | L-phenylalanine catabolic process (GO:0006559) | 3.94255887 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.94255887 |
| 30 | regulation of cGMP biosynthetic process (GO:0030826) | 3.80020585 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.66320982 |
| 32 | L-phenylalanine metabolic process (GO:0006558) | 3.66320982 |
| 33 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.64604016 |
| 34 | positive regulation of cGMP metabolic process (GO:0030825) | 3.51898656 |
| 35 | aromatic amino acid family catabolic process (GO:0009074) | 3.49672338 |
| 36 | nonmotile primary cilium assembly (GO:0035058) | 3.42891070 |
| 37 | cellular response to radiation (GO:0071478) | 3.41595781 |
| 38 | estrogen biosynthetic process (GO:0006703) | 3.40283835 |
| 39 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.34754812 |
| 40 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.33493333 |
| 41 | retinoid metabolic process (GO:0001523) | 3.31693942 |
| 42 | adaptation of signaling pathway (GO:0023058) | 3.28434149 |
| 43 | kynurenine metabolic process (GO:0070189) | 3.25890717 |
| 44 | sensory perception (GO:0007600) | 3.23788019 |
| 45 | alpha-linolenic acid metabolic process (GO:0036109) | 3.22363713 |
| 46 | diterpenoid metabolic process (GO:0016101) | 3.21037730 |
| 47 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.20663721 |
| 48 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.19396292 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 3.15770098 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.15770098 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.15770098 |
| 52 | bile acid biosynthetic process (GO:0006699) | 3.09241573 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.07917061 |
| 54 | terpenoid metabolic process (GO:0006721) | 3.05400940 |
| 55 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 3.01199259 |
| 56 | response to light stimulus (GO:0009416) | 3.01129420 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 2.99731497 |
| 58 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.99712844 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 2.99200738 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.98339487 |
| 61 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.97613716 |
| 62 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.96856202 |
| 63 | urea cycle (GO:0000050) | 2.96056230 |
| 64 | urea metabolic process (GO:0019627) | 2.96056230 |
| 65 | response to pheromone (GO:0019236) | 2.94859803 |
| 66 | cellular potassium ion homeostasis (GO:0030007) | 2.91280442 |
| 67 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.89807065 |
| 68 | tryptophan metabolic process (GO:0006568) | 2.88846689 |
| 69 | lipoprotein transport (GO:0042953) | 2.87561272 |
| 70 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.83187735 |
| 71 | neuron development (GO:0048666) | 2.82360656 |
| 72 | retina layer formation (GO:0010842) | 2.81950179 |
| 73 | protein localization to synapse (GO:0035418) | 2.79444187 |
| 74 | sodium ion export (GO:0071436) | 2.77704348 |
| 75 | regulation of protein activation cascade (GO:2000257) | 2.76326469 |
| 76 | retinol metabolic process (GO:0042572) | 2.75493635 |
| 77 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.73542211 |
| 78 | triglyceride homeostasis (GO:0070328) | 2.70249582 |
| 79 | acylglycerol homeostasis (GO:0055090) | 2.70249582 |
| 80 | potassium ion homeostasis (GO:0055075) | 2.68564274 |
| 81 | glyoxylate metabolic process (GO:0046487) | 2.68102925 |
| 82 | glutamate metabolic process (GO:0006536) | 2.67247866 |
| 83 | membrane hyperpolarization (GO:0060081) | 2.64876164 |
| 84 | cholesterol efflux (GO:0033344) | 2.63615627 |
| 85 | bile acid metabolic process (GO:0008206) | 2.63454481 |
| 86 | complement activation, alternative pathway (GO:0006957) | 2.62745914 |
| 87 | nitrogen cycle metabolic process (GO:0071941) | 2.62649113 |
| 88 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.62606073 |
| 89 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.61956987 |
| 90 | fatty acid elongation (GO:0030497) | 2.61714921 |
| 91 | negative regulation of fibrinolysis (GO:0051918) | 2.60405435 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.60164093 |
| 93 | protein carboxylation (GO:0018214) | 2.60164093 |
| 94 | regulation of complement activation (GO:0030449) | 2.59789543 |
| 95 | reverse cholesterol transport (GO:0043691) | 2.55649170 |
| 96 | retina homeostasis (GO:0001895) | 2.53686302 |
| 97 | regulation of fibrinolysis (GO:0051917) | 2.52369812 |
| 98 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 12.7702238 |
| 99 | rhodopsin mediated signaling pathway (GO:0016056) | 12.7429730 |
| 100 | retinal cone cell development (GO:0046549) | 11.8341804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.57407655 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.44443427 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.41973385 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.28271552 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.86223296 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.74218396 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.64544826 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.63412167 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.54280653 |
| 10 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 2.35740969 |
| 11 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.81268576 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80038235 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79753078 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70685087 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63914741 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.63145514 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55250765 |
| 18 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.54967415 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.54289988 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45834752 |
| 21 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42317974 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42260837 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42255729 |
| 24 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.39949508 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39734227 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39318253 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.38341920 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.38157291 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37488261 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36090633 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35327452 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34733520 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34663088 |
| 34 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31762902 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.28275038 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25427745 |
| 37 | AR_19668381_ChIP-Seq_PC3_Human | 1.24966239 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23961752 |
| 39 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22738992 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.18720348 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18291410 |
| 42 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.17882771 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16753804 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15335755 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14669551 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13553458 |
| 47 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11435854 |
| 48 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09621428 |
| 49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09320423 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08346627 |
| 51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06751800 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05798040 |
| 53 | TBL1_22424771_ChIP-Seq_293T_Human | 1.05483833 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04420437 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04318684 |
| 56 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04041580 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02966396 |
| 58 | * CBP_21632823_ChIP-Seq_H3396_Human | 1.02190341 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.01832109 |
| 60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.01832109 |
| 61 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01362044 |
| 62 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01184893 |
| 63 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.99298705 |
| 64 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99121001 |
| 65 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97836744 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93994890 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93806538 |
| 68 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93540099 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92232146 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91409797 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91409797 |
| 72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.88319851 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88039797 |
| 74 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86443266 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86431613 |
| 76 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86172825 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86125632 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 0.86115508 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84980686 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.84941993 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83578765 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82580185 |
| 83 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.82141724 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.81450208 |
| 85 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.81404223 |
| 86 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.80432501 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.78638835 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78610382 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78422627 |
| 90 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77463248 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77310356 |
| 92 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.76957380 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.76782663 |
| 94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.76245492 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.75800594 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75088172 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74948272 |
| 98 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.74879756 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74683701 |
| 100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.74506473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 9.73782466 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 8.75267056 |
| 3 | MP0005253_abnormal_eye_physiology | 5.90925924 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 5.57414507 |
| 5 | MP0002090_abnormal_vision | 3.56255063 |
| 6 | MP0005195_abnormal_posterior_eye | 3.51919369 |
| 7 | MP0001324_abnormal_eye_pigmentation | 3.17670062 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.05715281 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.01026648 |
| 10 | MP0005360_urolithiasis | 2.97893279 |
| 11 | MP0005391_vision/eye_phenotype | 2.86510564 |
| 12 | MP0005365_abnormal_bile_salt | 2.78269448 |
| 13 | MP0002229_neurodegeneration | 2.41366056 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.41049033 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25823478 |
| 16 | MP0001764_abnormal_homeostasis | 2.24620061 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.17438457 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.01785751 |
| 19 | MP0003252_abnormal_bile_duct | 1.82224338 |
| 20 | MP0005423_abnormal_somatic_nervous | 1.79663262 |
| 21 | MP0002752_abnormal_somatic_nervous | 1.66228761 |
| 22 | MP0001502_abnormal_circadian_rhythm | 1.59921695 |
| 23 | MP0001984_abnormal_olfaction | 1.44340152 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.43952574 |
| 25 | MP0004233_abnormal_muscle_weight | 1.24230899 |
| 26 | MP0002653_abnormal_ependyma_morphology | 1.14108337 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.13260761 |
| 28 | MP0002882_abnormal_neuron_morphology | 1.12523154 |
| 29 | MP0003868_abnormal_feces_composition | 1.11001544 |
| 30 | MP0009840_abnormal_foam_cell | 1.06773609 |
| 31 | MP0010368_abnormal_lymphatic_system | 0.95384372 |
| 32 | MP0001666_abnormal_nutrient_absorption | 0.94693913 |
| 33 | MP0001486_abnormal_startle_reflex | 0.94485809 |
| 34 | MP0005248_abnormal_Harderian_gland | 0.94061012 |
| 35 | MP0004782_abnormal_surfactant_physiolog | 0.93376941 |
| 36 | MP0004885_abnormal_endolymph | 0.87778934 |
| 37 | MP0005332_abnormal_amino_acid | 0.87664079 |
| 38 | MP0002332_abnormal_exercise_endurance | 0.87621481 |
| 39 | MP0005197_abnormal_uvea_morphology | 0.85656821 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 0.84188948 |
| 41 | MP0001986_abnormal_taste_sensitivity | 0.83412517 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 0.80142429 |
| 43 | MP0005394_taste/olfaction_phenotype | 0.73128109 |
| 44 | MP0005499_abnormal_olfactory_system | 0.73128109 |
| 45 | MP0003195_calcinosis | 0.72958309 |
| 46 | MP0000609_abnormal_liver_physiology | 0.70792330 |
| 47 | MP0005083_abnormal_biliary_tract | 0.66255261 |
| 48 | MP0002272_abnormal_nervous_system | 0.64610973 |
| 49 | MP0005376_homeostasis/metabolism_phenot | 0.63998808 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 0.63914943 |
| 51 | MP0004270_analgesia | 0.63139772 |
| 52 | MP0008789_abnormal_olfactory_epithelium | 0.61761468 |
| 53 | MP0003634_abnormal_glial_cell | 0.60599315 |
| 54 | MP0009697_abnormal_copulation | 0.57404082 |
| 55 | MP0002127_abnormal_cardiovascular_syste | 0.57187751 |
| 56 | MP0003880_abnormal_central_pattern | 0.56077952 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54467196 |
| 58 | MP0010386_abnormal_urinary_bladder | 0.53102491 |
| 59 | MP0005187_abnormal_penis_morphology | 0.52402063 |
| 60 | MP0002064_seizures | 0.52100963 |
| 61 | MP0003890_abnormal_embryonic-extraembry | 0.50445111 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 0.47742708 |
| 63 | MP0005595_abnormal_vascular_smooth | 0.46742485 |
| 64 | MP0001286_abnormal_eye_development | 0.46563977 |
| 65 | MP0005670_abnormal_white_adipose | 0.44363222 |
| 66 | MP0004130_abnormal_muscle_cell | 0.43789481 |
| 67 | MP0002909_abnormal_adrenal_gland | 0.43339337 |
| 68 | MP0002067_abnormal_sensory_capabilities | 0.42880762 |
| 69 | MP0009046_muscle_twitch | 0.42045858 |
| 70 | MP0003635_abnormal_synaptic_transmissio | 0.41060124 |
| 71 | MP0002928_abnormal_bile_duct | 0.40603475 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 0.39981216 |
| 73 | MP0009764_decreased_sensitivity_to | 0.39838818 |
| 74 | MP0001661_extended_life_span | 0.39827935 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 0.38679231 |
| 76 | MP0002822_catalepsy | 0.38165120 |
| 77 | MP0004036_abnormal_muscle_relaxation | 0.37870233 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.37725514 |
| 79 | MP0005334_abnormal_fat_pad | 0.37700343 |
| 80 | MP0001963_abnormal_hearing_physiology | 0.37524552 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 0.37202175 |
| 82 | MP0004924_abnormal_behavior | 0.36389468 |
| 83 | MP0005386_behavior/neurological_phenoty | 0.36389468 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.36371800 |
| 85 | MP0005535_abnormal_body_temperature | 0.35641593 |
| 86 | MP0001346_abnormal_lacrimal_gland | 0.35215914 |
| 87 | MP0002697_abnormal_eye_size | 0.35134831 |
| 88 | MP0002063_abnormal_learning/memory/cond | 0.34610982 |
| 89 | MP0005266_abnormal_metabolism | 0.34147174 |
| 90 | MP0001968_abnormal_touch/_nociception | 0.32709542 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.31903684 |
| 92 | MP0008872_abnormal_physiological_respon | 0.31759323 |
| 93 | MP0004085_abnormal_heartbeat | 0.31427622 |
| 94 | MP0002971_abnormal_brown_adipose | 0.30667447 |
| 95 | MP0002572_abnormal_emotion/affect_behav | 0.28871571 |
| 96 | MP0004742_abnormal_vestibular_system | 0.28377168 |
| 97 | MP0008775_abnormal_heart_ventricle | 0.28194950 |
| 98 | MP0010030_abnormal_orbit_morphology | 0.27249875 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 0.27241108 |
| 100 | MP0003633_abnormal_nervous_system | 0.27197632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.64848725 |
| 2 | Abnormal rod and cone electroretinograms (HP:0008323) | 9.23828721 |
| 3 | Central scotoma (HP:0000603) | 8.53161205 |
| 4 | Pigmentary retinal degeneration (HP:0001146) | 8.24560042 |
| 5 | Dyschromatopsia (HP:0007641) | 8.09161041 |
| 6 | Chorioretinal atrophy (HP:0000533) | 8.00435309 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 7.99248421 |
| 8 | Scotoma (HP:0000575) | 7.39349060 |
| 9 | Pendular nystagmus (HP:0012043) | 7.08054265 |
| 10 | Decreased central vision (HP:0007663) | 6.63129246 |
| 11 | Abolished electroretinogram (ERG) (HP:0000550) | 6.61436570 |
| 12 | Attenuation of retinal blood vessels (HP:0007843) | 6.39473412 |
| 13 | Photophobia (HP:0000613) | 5.06444948 |
| 14 | Type II diabetes mellitus (HP:0005978) | 5.04075159 |
| 15 | Cone-rod dystrophy (HP:0000548) | 5.03890923 |
| 16 | Posterior subcapsular cataract (HP:0007787) | 5.00984492 |
| 17 | Severe visual impairment (HP:0001141) | 4.91469422 |
| 18 | Macular degeneration (HP:0000608) | 4.89981009 |
| 19 | Vitreoretinal degeneration (HP:0000655) | 4.86456998 |
| 20 | Increased corneal curvature (HP:0100692) | 4.65190601 |
| 21 | Keratoconus (HP:0000563) | 4.65190601 |
| 22 | Constricted visual fields (HP:0001133) | 4.32540088 |
| 23 | Retinitis pigmentosa (HP:0000510) | 3.95189911 |
| 24 | Choroideremia (HP:0001139) | 3.84255520 |
| 25 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.54653639 |
| 26 | Subcapsular cataract (HP:0000523) | 3.20894706 |
| 27 | Progressive visual loss (HP:0000529) | 2.97488668 |
| 28 | Retinal atrophy (HP:0001105) | 2.87020054 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 2.43592133 |
| 30 | Congenital sensorineural hearing impairment (HP:0008527) | 2.39561287 |
| 31 | Optic disc pallor (HP:0000543) | 2.28137895 |
| 32 | Deep venous thrombosis (HP:0002625) | 2.18717156 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.15681477 |
| 34 | Wide nasal bridge (HP:0000431) | 2.14537740 |
| 35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.01937475 |
| 36 | Congenital stationary night blindness (HP:0007642) | 14.1507694 |
| 37 | Bony spicule pigmentary retinopathy (HP:0007737) | 10.5565918 |
| 38 | Polar cataract (HP:0010696) | 1.86945404 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 1.84557468 |
| 40 | Gait imbalance (HP:0002141) | 1.82468040 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 1.80959903 |
| 42 | Xanthomatosis (HP:0000991) | 1.80889104 |
| 43 | Congenital primary aphakia (HP:0007707) | 1.80130929 |
| 44 | Hypobetalipoproteinemia (HP:0003563) | 1.72863733 |
| 45 | Severe Myopia (HP:0011003) | 1.70815447 |
| 46 | Abnormal gallbladder physiology (HP:0012438) | 1.58667279 |
| 47 | Cholecystitis (HP:0001082) | 1.58667279 |
| 48 | Nephrogenic diabetes insipidus (HP:0009806) | 1.56579220 |
| 49 | Complement deficiency (HP:0004431) | 1.52048618 |
| 50 | Hypoalphalipoproteinemia (HP:0003233) | 1.48941802 |
| 51 | Epileptic encephalopathy (HP:0200134) | 1.48366340 |
| 52 | Optic atrophy (HP:0000648) | 1.47958750 |
| 53 | Poor coordination (HP:0002370) | 1.47830954 |
| 54 | Dysdiadochokinesis (HP:0002075) | 1.46854108 |
| 55 | Hypolipoproteinemia (HP:0010981) | 1.46453966 |
| 56 | Epidermoid cyst (HP:0200040) | 1.45398963 |
| 57 | Horizontal nystagmus (HP:0000666) | 1.45322701 |
| 58 | Medial flaring of the eyebrow (HP:0010747) | 1.44895696 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 1.43018530 |
| 60 | Febrile seizures (HP:0002373) | 1.34954746 |
| 61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.29839715 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 1.26670342 |
| 63 | Hyperammonemia (HP:0001987) | 1.23420967 |
| 64 | Vaginal atresia (HP:0000148) | 1.18521644 |
| 65 | Ketosis (HP:0001946) | 1.18437725 |
| 66 | Joint hemorrhage (HP:0005261) | 1.18214753 |
| 67 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.17755236 |
| 68 | Hypoplasia of the fovea (HP:0007750) | 1.17755236 |
| 69 | Abnormality of the fovea (HP:0000493) | 1.16498618 |
| 70 | Fat malabsorption (HP:0002630) | 1.14665860 |
| 71 | Septo-optic dysplasia (HP:0100842) | 1.12798944 |
| 72 | Genital tract atresia (HP:0001827) | 1.12522501 |
| 73 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.11808277 |
| 74 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.11793469 |
| 75 | Abnormality of methionine metabolism (HP:0010901) | 1.10446206 |
| 76 | Hyperglycinemia (HP:0002154) | 1.09969650 |
| 77 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.09863363 |
| 78 | True hermaphroditism (HP:0010459) | 1.08723006 |
| 79 | Hypercholesterolemia (HP:0003124) | 1.08195943 |
| 80 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.06418565 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 1.05718910 |
| 82 | Chronic hepatic failure (HP:0100626) | 1.03336454 |
| 83 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.03039856 |
| 84 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.02569169 |
| 85 | Conjugated hyperbilirubinemia (HP:0002908) | 1.01240412 |
| 86 | Retinal detachment (HP:0000541) | 1.00767169 |
| 87 | Progressive cerebellar ataxia (HP:0002073) | 1.00244908 |
| 88 | Abnormality of complement system (HP:0005339) | 1.00164802 |
| 89 | Hypoglycemic coma (HP:0001325) | 0.98482300 |
| 90 | Skin nodule (HP:0200036) | 0.97206313 |
| 91 | Abnormality of the lower motor neuron (HP:0002366) | 0.96156486 |
| 92 | Pancreatic fibrosis (HP:0100732) | 0.95859434 |
| 93 | Prolonged QT interval (HP:0001657) | 0.95512029 |
| 94 | Recurrent sinusitis (HP:0011108) | 0.95334971 |
| 95 | Vascular calcification (HP:0004934) | 0.93618568 |
| 96 | Status epilepticus (HP:0002133) | 0.93564195 |
| 97 | Hyperventilation (HP:0002883) | 0.91636383 |
| 98 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.91583160 |
| 99 | Absence seizures (HP:0002121) | 0.90953966 |
| 100 | Cholelithiasis (HP:0001081) | 0.90592139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 9.10347944 |
| 2 | PBK | 5.46618602 |
| 3 | PINK1 | 3.55470716 |
| 4 | INSRR | 2.48821706 |
| 5 | IRAK2 | 2.25484644 |
| 6 | CAMK1D | 1.91639335 |
| 7 | SIK1 | 1.90035837 |
| 8 | CAMK1G | 1.87507542 |
| 9 | TAOK3 | 1.77210162 |
| 10 | NEK1 | 1.66733308 |
| 11 | MAP3K10 | 1.63777713 |
| 12 | MAP3K4 | 1.63733732 |
| 13 | PAK6 | 1.58435113 |
| 14 | STK38 | 1.57234647 |
| 15 | SGK223 | 1.47876465 |
| 16 | SGK494 | 1.47876465 |
| 17 | SIK2 | 1.42675261 |
| 18 | MARK1 | 1.31497479 |
| 19 | MAP2K4 | 1.30182363 |
| 20 | ERBB2 | 1.29596387 |
| 21 | MAP3K7 | 1.28414551 |
| 22 | MAPK12 | 1.28049232 |
| 23 | MAPK7 | 1.20560187 |
| 24 | PRKCZ | 1.20402077 |
| 25 | BCKDK | 1.14274749 |
| 26 | HIPK2 | 1.13091885 |
| 27 | PRKAA1 | 1.12601149 |
| 28 | LATS1 | 1.10099745 |
| 29 | FRK | 1.09271337 |
| 30 | SGK2 | 1.05704750 |
| 31 | RIPK1 | 1.02513962 |
| 32 | BRD4 | 1.01286716 |
| 33 | SGK3 | 1.00205739 |
| 34 | ICK | 0.99384670 |
| 35 | PRKAA2 | 0.98779073 |
| 36 | AKT3 | 0.97606168 |
| 37 | DYRK1A | 0.95506245 |
| 38 | ADRBK1 | 0.94895285 |
| 39 | CSNK1D | 0.91108073 |
| 40 | CAMK2D | 0.90962082 |
| 41 | DYRK1B | 0.88511180 |
| 42 | CDK12 | 0.87812639 |
| 43 | PRKCH | 0.86525657 |
| 44 | MAP2K7 | 0.86129317 |
| 45 | STK38L | 0.85861855 |
| 46 | CDK3 | 0.84825249 |
| 47 | FGFR4 | 0.82200103 |
| 48 | PKN1 | 0.82107778 |
| 49 | PHKG2 | 0.80394224 |
| 50 | PHKG1 | 0.80394224 |
| 51 | PRKCB | 0.77237875 |
| 52 | PRKACG | 0.73595665 |
| 53 | PKN2 | 0.71469695 |
| 54 | CAMKK1 | 0.71426701 |
| 55 | CDK9 | 0.65813967 |
| 56 | RPS6KA3 | 0.64334416 |
| 57 | FES | 0.62455311 |
| 58 | FGFR2 | 0.60801340 |
| 59 | ERN1 | 0.60093134 |
| 60 | MINK1 | 0.59751871 |
| 61 | PRKD3 | 0.52190484 |
| 62 | CAMK4 | 0.51202492 |
| 63 | CAMK1 | 0.48731504 |
| 64 | RPS6KA4 | 0.47959326 |
| 65 | SGK1 | 0.47953380 |
| 66 | EPHA3 | 0.47665620 |
| 67 | MAP3K13 | 0.47494034 |
| 68 | PRKCA | 0.46128411 |
| 69 | PRPF4B | 0.44760434 |
| 70 | GSK3B | 0.44160377 |
| 71 | PRKD2 | 0.43979325 |
| 72 | TAOK2 | 0.43805247 |
| 73 | PNCK | 0.43243862 |
| 74 | PAK3 | 0.42540186 |
| 75 | PRKACA | 0.41337481 |
| 76 | PRKCG | 0.40958030 |
| 77 | MAPK10 | 0.40824039 |
| 78 | CAMK2A | 0.40580281 |
| 79 | CSNK1G2 | 0.40025943 |
| 80 | CDK5 | 0.39952702 |
| 81 | PDK1 | 0.39192443 |
| 82 | PIK3CA | 0.38933177 |
| 83 | AKT2 | 0.37261311 |
| 84 | MAPK14 | 0.36213979 |
| 85 | CSNK1E | 0.35745251 |
| 86 | MAPK9 | 0.35650676 |
| 87 | MAP3K6 | 0.33722716 |
| 88 | JAK1 | 0.33062844 |
| 89 | GRK5 | 0.32494131 |
| 90 | RPS6KB1 | 0.32439248 |
| 91 | CSNK1A1L | 0.31323418 |
| 92 | WNK1 | 0.31067008 |
| 93 | PRKG1 | 0.31022293 |
| 94 | MAPK11 | 0.30891168 |
| 95 | STK11 | 0.30630298 |
| 96 | PRKACB | 0.30104870 |
| 97 | PRKDC | 0.29971208 |
| 98 | RET | 0.29844213 |
| 99 | PTK6 | 0.29521116 |
| 100 | PRKD1 | 0.29256448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.73639014 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.45955845 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.41684175 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04851678 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 12.2317304 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73363393 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.63687991 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42089787 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.41565972 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.40165940 |
| 11 | ABC transporters_Homo sapiens_hsa02010 | 1.30953249 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29784471 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27996694 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27365652 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25508256 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.23386181 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15211636 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14500347 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14035039 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11976414 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09028881 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06170049 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.03874664 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02311989 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01502645 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 0.98004173 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95632304 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90095508 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90012757 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89134586 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86473409 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85238464 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84796104 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83643511 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83177156 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82314040 |
| 37 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81308459 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 0.80341172 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77921244 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77521923 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77358579 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77337062 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74188829 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73162929 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 0.71029157 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70429782 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 0.67779639 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67767333 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67240140 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66537375 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66190537 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65186614 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64278156 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63849623 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62662925 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62465199 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.62382111 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61887767 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60332011 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60240030 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60007997 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59984369 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58113806 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.53304914 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50194152 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49594530 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49309771 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43687593 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39878854 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38856222 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35947437 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35628310 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33235342 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33099985 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32908041 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32814194 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32504632 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31995385 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31825265 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29114660 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27131226 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26722477 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.26446832 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26315072 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26006698 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.23618233 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23487396 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.22919185 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22768812 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.22007007 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21671343 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21313544 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.19575151 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19570677 |
| 95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.18323381 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17878685 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17536236 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.17087842 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14014950 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13201989 |

